A few thoughts today as our wacky world has gone off the reservation in terms of wackiness, so let’s get right to it
Dexcom has a blowout quarter increases revenue guidance so naturally the stock sinks almost 5.5%. Now we get that some long time Dexcom investors are taking profits and honestly, we can’t blame them given the how shares have skyrocketed over the past year or so. And we do get concerns over upcoming tougher quarterly comparisons and we somewhat understand concerns over the coming of the Libre 2. Still these concerns are overblown when you look at the strength of the CGM market and the company’s proven track record. Therefore we shall offer some advice once given to us by Momma Kliff; “This is a great opportunity so don’t screw it up by overthinking it.”
Just to show that no HIGH lasts forever after going higher yesterday shares of Valeritas were also down today. But hey there might some good on the horizon as check this out;
“Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that it has signed an agreement with Sanofi (NYSE:SNY) to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute Cannabinoid Overdose (ACO).”
Wonder if this drug can be delivered using the Valeritas h-pump?
This from the Sasquatch watch;
“Bigfoot Biomedical today announced an agreement with Pittsburgh-based Allegheny Health Network (AHN) to further develop Bigfoot’s Unity investigational insulin delivery wireless platform.
The diabetes startup described Unity as a first-in-kind, data-driven solution for optimizing insulin dosing and delivery. Bigfoot will work alongside AHN endocrinologists and primary care doctors to refine Unity’s clinical workflow features.”
Naturally this deal does not involve any money at least none that was made public or that anyone is aware of anyway. Which is typical of the deals done by BigMouth and several of their competitors. Perhaps this is the reason the company is beginning to lose key people while laying off employees. We’re not sure about everyone else but it sure as hell helps when a company makes money and BigMouth isn’t and likely won’t for some time assuming of course it can survive.
Come to think of its Bigfoot is the perfect name for this company as it’s based on a mythical figure and given that Bigfoot is a mythical company without one product on the market or one revenue generating deal this myth like most myths could soon become a bankrupt myth. Which again is appropriate as the company began by buying the assets of Asante an insulin pump company that went bankrupt. This isn’t just ironic it’s also somewhat poetic.
Ok and this really has nothing to do with wackiness, but we have decided to make a change to how we deliver our posts. As everyone should know Diabetic Investor is a COPYRIGHTED publication and is not to be shared with someone who is NOT a PAYING subscriber without our permission. Now those who have asked permission to share know that 9 times out of 10 we grant permission to share. However illegal sharing has reached epic proportions and we have decided to take some steps to limit this illegal activity.
Beginning September 1, 2019 we will send emails which contain a snippet of the entire post, but users will have to log onto the site using their username (their email address) and password to access the entire post. Now before everyone has a kanipshin (if you’re not sure what that means Google it or ask Momma Kliff) we know that not everyone knows their password, hence the reason we are giving advanced notice of this change. If you aren’t sure what your password is, you have two options contact your license administrator or email us here and we’ll be delighted to help.
Just as a reminder using the same login information you will also have access to the archives section of the site which includes everything we have ever written and is searchable.
As always if you have any questions or need help feel free to reach out. Thanks for understanding and enjoy your weekend.